Get started
Author

Lénaïg Le Clech

Observed names: L. Le Clech, Le Clech, Lénaïg, Lenaig Le Clech, Lenaïg Le Clech
Observed institutions: Université de Bretagne Occidentale, Hôpital Saint-Antoine, Centre Hospitalier de Cornouaille, Centre Hospitalier Universitaire de Limoges, Centre Hospitalier Régional Universitaire de Brest, Université de Bretagne Occidentale
ORCID: 0000-0001-5586-9772
Observed ORCID: 0000-0001-5586-9772
OpenAlex ID: A5086160671
Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study
2018 · Lenaïg Le Clech, Jean-Philippe Talarmin, et al. · Scandinavian Journal of Infectious Diseases · 83
Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification
2020 · Didier Bronnimann, Dea Garcia-Hermoso, et al. · Medical Mycology · 48
PDF
Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study
2020 · Anne Laure Roupie, Alexis Guedon, et al. · Seminars in Arthritis and Rheumatism · 40
PDF
Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia
2021 · Vincent Jachiet, Guillaume Moulis, et al. · Haematologica · 30
Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study
2020 · Sylvie Tondeur, Franciane Paul, et al. · Leukemia · 20
Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis
2022 · Sandrine Lemoine, Clelia Mornet, et al. · Haematologica · 17
PDF
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real‐life study
2021 · Thibault Comont, Mathieu Meunier, et al. · British Journal of Haematology · 17
Severe CMV complication following maintenance therapy with rituximab
2013 · Lenaïg Le Clech, Jean-Christophe Ianotto, et al. · BMJ Case Reports · 16
PDF
Low-Dose DOACs in Very High-Risk MPNs: Less Bleeding But More Arterial Thrombotic Events
2022 · Laura Herbreteau, Loula Papageorgiou, et al. · SSRN Electronic Journal · 12
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study
2020 · Sophie Vantyghem, Pierre Peterlin, et al. · Haematologica · 12
PDF
The presence of monoclonal gammopathy in Ph-negative myeloproliferative neoplasms is associated with a detrimental effect on outcomes
2017 · Lenaïg Le Clech, Mehdi Sakka, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 12
Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia
2019 · Lenaïg Le Clech, Marie Uguen, et al. · Current Research in Translational Medicine · 10
PDF
Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm
2022 · Ronan Le Calloch, Bertrand Arnaud, et al. · Annals of Hematology · 7
Outcome of patients with accelerated and blast‐phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination—A FIM study
2025 · Corentin Orvain, Suzanne Tavitian, et al. · HemaSphere · 6
PDF
Clinical outcomes in patients in any phase of CML treated with ponatinib in France—Data from the TOPASE observational study
2024 · F. Huguet, A. Guerci‐Bresler, et al. · British Journal of Haematology · 6
PDF
CALR‐mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM
2024 · Laura Aubin, Rúben Vilas Boas, et al. · American Journal of Hematology · 6
PDF
Skin nodules in a patient with acute lymphoblastic leukaemia
2014 · Lenaïg Le Clech, Pascal Hutin, et al. · BMJ Case Reports · 6
Efficacy and Safety of Luspatercept +/- Erythropoiesis-Stimulating Agent (ESA) in Patients with Myelodysplastic Syndromes with Ring Sideroblasts (MDS-RS): A French Multicenter Prospective Real-Life Registry
2023 · Thibault Comont, Maud D'Aveni, et al. · Blood · 4
Eculizumab, a real-life successful treatment for refractory cold agglutinin–mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders
2021 · Laura Herbreteau, Ronan Le Calloch, et al. · Annals of Hematology · 3
Epidemiology of Bacterial Infections during Induction Chemotherapy in Adult Patients with Acute Lymphoblastic Leukemia (ALL): Analysis of the Graall-2005 Study
2016 · Fressia Honeyman, Emmanuelle Tavernier, et al. · Blood · 3
Outcome of Patients with Accelerated and Blast-Phase Myeloproliferative Neoplasms Ineligible for Intensive Chemotherapy or Allogeneic Hematopoietic Cell Transplantation Treated By Azacitidine Alone or in Combination - a FIM Study
2024 · Corentin Orvain, Suzanne Tavitian, et al. · Blood · 2
Mononeuritis multiplex in a patient with B-cell prolymphocytic leukaemia: a diagnostic challenge
2013 · Lenaïg Le Clech, Marie Jeanne Rizcallah, et al. · BMJ Case Reports · 2
Diagnosis of a non-excretory myeloma
2013 · Fanny Mingant, Hélène Kerspern, et al. · Annales de biologie clinique · 2
Durable Responses With Front‐Line Rituximab in Autoimmune Cytopenias Associated With Indolent B‐Cell Clones
2025 · Yoann Zadro, Amélie Lusque, et al. · American Journal of Hematology · 1
PDF
Efficacy and safety of luspatercept with or without erythropoiesis‐stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real‐life study by the GFM
2025 · Maud D'Aveni, Laurence Schenone, et al. · British Journal of Haematology · 1
PDF
Works count: 45
Citation count: 367
H-index: 11
I10-index: 12
Year
Topic
Type